All corona articles
-
PHE/DH/DWP guidelinePHE management of staff exposure to COVID-19
This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results
-
Information
COVID-19 hub for primary care
The Guidelines team has produced this directory of COVID-19 information and guidance for primary care. Included on this page is a collection of key guidance and advice from PHE and the NHS, as well as a list of information for specific groups from a range of professional bodies
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
Information
COVID-19 hub for community pharmacy
The Guidelines for Pharmacy team has produced the following directory of COVID-19 information and guidance for community pharmacy. Included on this page is a collection of key guidance and advice from PSNC, FIP, and NHS, as well as a list of information for specific groups from a range of professional bodies.
-
NHS guideline
PHE maintaining immunisation programmes during COVID-19
A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
News
New guidance published on SARS-CoV-2 reinfection
The new recommendations from PHE aim to help clinicians identify and manage suspected cases of SARS-CoV-2 reinfection
-
Independent professional body guideline
WHO COVID-19 clinical management guideline
An easy-to-digest summary of World Health Organization guidance for clinicians involved in the care of patients with suspected or confirmed COVID-19
-
NICE guideline
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection
-
Independent professional body guideline
HEART UK Managing hyperlipidaemia and COVID-19
A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19
-
News
PHE publishes new guidance on managing COVID-19 variants of concern
Amid concerns around the spread of new COVID-19 variants, PHE has published guidance for identifying and managing possible or confirmed cases
-
News
COVID-19 vaccinations to be delivered by high street pharmacies from today
As the NHS accelerates its largest vaccination programme to date, high street pharmacies have begun delivering protective COVID-19 vaccinations
-
News
UK government publishes largest ever vaccination delivery plan
The British government has set out a plan that aims to vaccinate millions of people against COVID-19 by the spring
-
News
Moderna COVID-19 vaccine approved by MHRA
The Moderna vaccine has become the third COVID-19 vaccine—and the second mRNA COVID-19 vaccine—to be approved for use in the UK
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
News
NICE, SIGN and RCGP to develop new guideline on long-term effects of COVID-19
Further details have been released about the forthcoming guideline by NICE, SIGN and the Royal College of Practitioners (RCGP) on post-COVID syndrome
-
NHS guideline
NHS England COVID-19 guidance for community pharmacy
This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
